Prospective Trial of Neutrophil/Lymphocyte Ratio and Other Blood Counts as Biomarkers of Survival among Patients with High-Grade Soft Tissue Sarcomas Treated with Pegylated Liposomal Doxorubicin and Ifosfamide.

Cancers (Basel) · 2022 · PMC9316699 · PMID 35884480

Europe PMC DOI

hedged sentences

0.0690

closest p · 1.4× alpha

0.0690

boldest claim

The sentences

a strong trendp = 0.069so close (0.05 < p ≤ 0.1)

In the present study, we found a statistically significant association between pretreatment NLR and OS using a cutoff value of ≥2 and a strong trend toward association with a cutoff value of ≥5 ( p = 0.069).

also in 5,725 other papers

a slight trendno p-value reported

We observed a slight trend toward an association of ALC before cycle 2 with both PFS and OS, although the potential effect was not large.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.